cause similar phenotypes to those of vab-1 mutants.
Mutations in the vab-2 gene cause defects in epidermal
To test whether VAB-2/EFN-1 binds VAB-1, we tested whether the extracellular domain of VAB-1 expressed morphogenesis like those of vab-1 (Brenner, 1974). Examination of sequence data for the vab-2 genomic reas a soluble fusion protein with alkaline phosphatase (VAB-1-AP) could bind 293T cells expressing VAB-2/ gion revealed a predicted ephrin gene; all vab-2 alleles cause sequence alterations in this gene (Table 1) , show- Figure 2G , which vab-2 corresponds to efn-1; in this paper we will refer to this gene as vab-2/efn-1.
EFN-1. VAB-1-AP binding to cells expressing VAB-2/ EFN-1 was detectable by staining for AP (Figures 2F ing that this gene is vab-2. Four C. elegans ephrin (efn) genes have been identified (Wang et al., 1999), among and 2G) and was abolished by pretreatment with PI-PLC or with anti-VAB-2/EFN-1 antibodies (

and data not shown). VAB-1-AP colocalized with VAB-2 when bound to VAB-2-expressing cells (Figures 2H-2J). We confirmed the structure of the vab-2/efn-1 gene (see Experimental Procedures). VAB-2/EFN-1 is most
We measured the affinity of VAB-1-AP for VAB-2/EFN-1 in equilibrium binding experiments ( Figure 2K ). Specific similar to vertebrate ephrins (Pandey et al., 1995) . Vertebrate ephrins are GPI-anchored (ephrin-A) or transmembinding curves of VAB-1-AP to cells expressing VAB-2/ EFN-1 showed saturation, with a calculated K D of 5 nM, brane (ephrin-B) proteins. VAB-2/EFN-1 contains a predicted GPI attachment signal at its C terminus and thus comparable to vertebrate Eph receptor-ephrin K D s of 0.1-25 nM (Flanagan and Vanderhaeghen, 1998 ); negais structurally similar to vertebrate ephrin-As. The conserved domain of VAB-2/EFN-1 is significantly more tive controls showed lower binding and no saturation ( Figure 2K ). These data show that VAB-2/EFN-1 can bind similar to those of ephrin-Bs than to those of ephrinAs ( Figure 1C ). VAB-2 thus shares features with both VAB-1 with high affinity. Finally, we asked whether the missense mutations subfamilies of vertebrate ephrins. Five strong vab-2/ efn-1 alleles result in nonsense mutations (Table 1; Fig- caused by the vab-2 alleles e141 and e1208 affected the affinity of VAB-2/EFN-1 for VAB-1. The C90Y and ure 1B) and are probably null mutations. Two intermediate alleles, e141 and e1208, encode missense alter-P108L mutant VAB-2/EFN-1 proteins were expressed at equivalent levels to wild-type VAB-2/EFN-1 ( Figure 2C ), ations (C90Y and P108L) in the receptor binding domain. and did not show specific binding to VAB-1 ( Figure 2L ). Thus, mutations that reduced the affinity of VAB-2/ VAB-2/EFN-1 is GPI-Anchored and Binds VAB-1 with High Affinity EFN-1 for VAB-1 also reduced vab-2/efn-1 function. Vertebrate EphA receptors bind ephrin-A ligands, and EphB receptors bind ephrin-B ligands (Gale et al., 1996) .
vab-2/efn-1 Mutants Display Defects VAB-1 is equally similar to the EphA and EphB receptor in Morphogenesis Similar to Those subfamilies (George et al., 1998) . Because VAB-1 and of vab-1 Mutants VAB-2/EFN-1 are divergent members of their families, vab-2/efn-1 mutations cause variable and incompletely we asked whether they bind one another with high affinpenetrant defects in epidermal morphogenesis (Table  ity . Full-length VAB-2/EFN-1 was expressed as a cell 1; Figure 3) . We analyzed the phenotypes caused by the surface protein in 293T cells ( Figure 2B ). To determine strong vab-2/efn-1 allele ju1 in detail. About 10% of whether VAB-2/EFN-1 was GPI-anchored, we incubated vab-2/efn-1 mutants arrested during embryonic stages; VAB-2/EFN-1-expressing cells with phosphatidylinosiabout 20% of vab-2/efn-1 animals arrested as larvae tol-specific phospholipase C (PI-PLC), an enzyme that due to defects in head and tail morphogenesis. About cleaves GPI anchors (Ferguson and Williams, 1988).
50% of vab-2/efn-1 adults displayed the "Notched-VAB-2/EFN-1 was released into the supernatant by PIhead" phenotype, resulting from aberrant morphogene-PLC treatment (Figures 2A and 2D) , showing that VAB-2/ EFN-1 is GPI anchored.
sis of head epidermis ( Figure 3J ). The expression of in epidermal enclosure ( Figure 3B ). Because most vab-2/ efn-1 mutants displayed phenotypes similar to those of vab-1 mutants, we classified them using the same criteria (George et al., 1998) . Twelve percent of vab-2/ efn-1 embryos displayed severe defects in gastrulation cleft closure and arrested in epidermal enclosure (class I and II phenotypes; Figures 3G and 3H ). Sixteen percent of vab-2/efn-1 embryos displayed defects in gastrulation cleft closure, underwent normal epidermal enclosure, and elongated to the 2-or 3-fold stage, when they ruptured in the head ( Figure 3I) ; this phenotype is similar to the vab-1 class IV phenotype. Most vab-2/efn-1 embryos (72%) displayed mild defects in morphogenesis (class V; Figure 3J ). The phenotypes of vab-2/efn-1 mutants were thus largely indistinguishable from those of vab-1 mutants. The major difference was that vab-1 null mutations caused more penetrant defects than those of strong vab-2/efn-1 mutants (see below). vab-2/efn-1 adults were also more frequently egg-laying defective than vab-1 mutants. Thus, vab-2/efn-1 mutant phenotypes were mostly overlapping with those of vab-1 mutants, consistent with vab-2/efn-1 and vab-1 functioning in the same process.
VAB-2/EFN-1 Is Expressed in a Subset of Neurons during Embryogenesis, Adjacent to VAB-1-Expressing Neurons
To determine the cells in which VAB-2/EFN-1 was expressed, we made anti-VAB-2/EFN-1 antisera. These antisera detected VAB-2/EFN-1 in animals that overex- 
VAB-2/EFN-1 Can Function in Neurons to Regulate Epidermal Morphogenesis
The expression pattern of VAB-2/EFN-1 suggested that, like VAB-1, it might function nonautonomously in the developing nervous system for epidermal development. We first tried to address this using genetic mosaic analysis and found that vab-2/efn-1 was required in several lineages that generate both epidermis and neurons ( Figure 6A ). These data suggest that fore act in a kinase-independent pathway that is also affected by the vab-1(e699) mutation. vab-2/efn-1 functions mainly in the same pathway as vab-1.
Mutations that disrupt the kinase domain of VAB-1 [vab-1(k)] do not eliminate vab-1 function, suggesting Discussion that VAB-1 has both kinase-dependent and kinase-independent functions (George et al., 1998). As VAB-2/EFN-1
We previously reported that vab-1 encodes a C. elegans Eph receptor tyrosine kinase that is required in neurons is a GPI-anchored ephrin, we predicted that it would mediate the kinase-dependent function of VAB-1, and for normal neural and epidermal morphogenesis. Here To show colocalization of VAB-1-AP bindTransgenic lines bearing the above constructs injected at high concentrations (Ͼ30 ng/l) frequently displayed lethality and moring and VAB-2/EFN-1, VAB-1-AP (900 ng/ml) was bound to VAB-2/ EFN-1 expressing cells in complete medium for 1 hr at 37ЊC. Cells phogenetic defects. For rescue tests we reduced the concentration of the constructs to levels that caused Ͻ5% abnormal phenotypes were washed and fixed as above. VAB-1-AP was detected by anti-AP monoclonals (Genzyme) at 1:1000 dilution, and VAB-2/EFN-1 in a vab-2/efn-1(ϩ) background, with the exception of the Ppax-3::VAB-2/EFN-1 arrays, which cause 15%-20% Vab phenotypes in detected by anti-VAB-2/EFN-1 antisera (1:500). Primary antibodies were incubated for 2 hr to overnight at room temperature, and stainadults. Punc-119::VAB-2/EFN-1 was injected at 15 ng/l (arrays juEx213, juEx214); Ppax-3::VAB-2/EFN-1 was injected at 30 ng/l ing visualized using appropriate secondary antibodies. For the Western blot analysis of VAB-2/EFN-1, cells from a 25 (arrays juEx215, juEx216); Pjam-1::VAB-2/EFN-1 was injected at 10 ng/l (arrays juEx217, juEx218). All constructs were injected with cm 2 flask of confluent cells were washed off, spun (150 l pellets) and resuspended in 1 ml 2ϫ sample buffer, boiled, and 20 l loaded pRF4 at 30 ng/l. Transgenic arrays transmitting to 30%-40% of progeny were crossed into a vab-2/efn-1(ju1) background and resonto a 15% acrylamide gel, subjected to SDS-PAGE, and electroblotted onto nitrocellulose. Anti-VAB-2/EFN-1 was used at 1:1000 cue of Vab-2 phenotypes scored in blind tests.
Strong expression is also seen in the metacorpus, isthmus, and valve regions of the pharynx. (D) Triple label immunofluorescence (confocal section) showing VAB-2/EFN-1 (green), VAB-1::GFP (blue), and MH27 (red). Lateral view during early enclosure; leading edges of epidermal cells are arrowed. (E and F) VAB-2/EFN-1 and VAB-1::GFP expression after leading cells have met at the ventral midline (arrow). Ventral views; (E) is a confocal section showing only VAB-2/EFN-1 and VAB-1::GFP channels; (F) is a confocal projection of the ventral half of the embryo in all three channels. VAB-1::GFP and VAB-2/ EFN-1 expressing cells form distinct, adjacent populations. (G and H) VAB-2/EFN-1 expression in vab-1(e2) mutant embryos. VAB-2/EFN-1-expressing cells become more spread out, compare brackets showing extent of VAB-2/EFN-1 staining in (A) and (B) versus (G) and (H). Spreading of VAB-2/EFN-1-expressing cells was seen in 70% (
dilution. Anti-rabbit HRP-conjugated antibodies (Amersham) were used at 1:5000 dilution and detected using Super Signal (Pierce).
VAB-2/EFN-1 Antibody Production and C. elegans Immunocytochemistry
To generate mutant forms of VAB-2/EFN-1 in pcDNA1, we designed primers containing the missense mutations in e141 and To express VAB-2/EFN-1 in bacteria we cloned residues 27 to 240 of VAB-2/EFN-1 into pGEX4T3 (Pharmacia). GST-VAB-2 fusion proe1208 and used these primers in PCRs. First, two PCRs were carried out using vab-2/efn-1 cDNA as template: one, using a 5Ј sense teins were induced in E. coli TG1 cells, purified by SDS-PAGE, and injected into rabbits. Anti-GST-VAB-2 antisera were preabsorbed primer specific for vab-2/efn-1 and the antisense primer of the complementary mutated primer; and two, using the sense primer of the by incubation with protein acetone powders derived from 293T cells, complementary mutated primer and a 3Ј anti-sense primer specific E. coli, and vab-2(ju1) worms, and by binding to a GST-VAB-2/ for vab-2/efn-1. The two PCR products were pooled and used as EFN-1 Affigel-15 (BioRad) column, followed by extensive washing templates in a third PCR using the original 5Ј and 3Ј vab-2/efn-1 and elution.
primers to generate a vab-2/efn-1 cDNA containing the desired muTo stain C. elegans embryos, we fixed the embryos in methanol tation. Clones were confirmed by sequencing. and 2% paraformaldehyde and permeabilized them by freeze-thawing (Finney and Ruvkun, 1990 ). Data were collected from strain
